{"slideshow_credits": null, "snippet": "Pfizer said in a regulatory filing with the Securities and Exchange Commission that it was taking a $450 million charge against first-quarter earnings to settle the case.", "abstract": "Pfizer settles lawsuit filed by Brigham Young University for $450 million over development of the painkiller Celebrex; company will take a $450 million charge against first-quarter earnings for the settlement.", "section_name": "Health", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/05/02/health/pfizer-settles-byu-lawsuit-over-development-of-celebrex.html", "lead_paragraph": "Pfizer said in a regulatory filing with the Securities and Exchange Commission that it was taking a $450 million charge against first-quarter earnings to settle the case.", "headline": {"main": "Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex", "print_headline": "Pfizer Settles College\u2019s Lawsuit Over Development of Celebrex"}, "_id": "515da610cf28d0219d001b14", "word_count": "279", "multimedia": [], "pub_date": "2012-05-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Suits and Litigation", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Celebrex (Drug)", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "Pfizer Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Colleges and Universities", "name": "subject", "is_major": "Y", "rank": "6"}, {"value": "Brigham Young University", "name": "organizations", "is_major": "Y", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "News"}